NZ237722A - Certain 1,4-dihydro-pyridine carboxylic acid esters and pharmaceutical compositions thereof - Google Patents

Certain 1,4-dihydro-pyridine carboxylic acid esters and pharmaceutical compositions thereof

Info

Publication number
NZ237722A
NZ237722A NZ237722A NZ23772291A NZ237722A NZ 237722 A NZ237722 A NZ 237722A NZ 237722 A NZ237722 A NZ 237722A NZ 23772291 A NZ23772291 A NZ 23772291A NZ 237722 A NZ237722 A NZ 237722A
Authority
NZ
New Zealand
Prior art keywords
pyridine
dihydro
dimethyl
dicarboxylate
cyclopropyl
Prior art date
Application number
NZ237722A
Other languages
English (en)
Inventor
Otto Behner
Hartmut Wollweber
Bruno Rosen
Siegfried Zaiss
Siegfried Goldmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to NZ250085A priority Critical patent/NZ250085A/en
Publication of NZ237722A publication Critical patent/NZ237722A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ237722A 1990-04-11 1991-04-08 Certain 1,4-dihydro-pyridine carboxylic acid esters and pharmaceutical compositions thereof NZ237722A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ250085A NZ250085A (en) 1990-04-11 1991-04-08 Use of dihydropyridinedicarboxylic acid esters as pharmaceuticals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4011695A DE4011695A1 (de) 1990-04-11 1990-04-11 Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
NZ237722A true NZ237722A (en) 1995-10-26

Family

ID=6404197

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ237722A NZ237722A (en) 1990-04-11 1991-04-08 Certain 1,4-dihydro-pyridine carboxylic acid esters and pharmaceutical compositions thereof

Country Status (18)

Country Link
US (2) US5234935A (cg-RX-API-DMAC10.html)
EP (1) EP0451654B1 (cg-RX-API-DMAC10.html)
JP (1) JP3012352B2 (cg-RX-API-DMAC10.html)
KR (1) KR0180741B1 (cg-RX-API-DMAC10.html)
AT (1) ATE111079T1 (cg-RX-API-DMAC10.html)
AU (1) AU642992B2 (cg-RX-API-DMAC10.html)
CA (1) CA2040062A1 (cg-RX-API-DMAC10.html)
DE (2) DE4011695A1 (cg-RX-API-DMAC10.html)
DK (1) DK0451654T3 (cg-RX-API-DMAC10.html)
ES (1) ES2063998T3 (cg-RX-API-DMAC10.html)
FI (1) FI101377B (cg-RX-API-DMAC10.html)
HU (2) HUT59905A (cg-RX-API-DMAC10.html)
IE (1) IE64452B1 (cg-RX-API-DMAC10.html)
IL (1) IL97796A (cg-RX-API-DMAC10.html)
NZ (1) NZ237722A (cg-RX-API-DMAC10.html)
PT (1) PT97300B (cg-RX-API-DMAC10.html)
TW (1) TW197423B (cg-RX-API-DMAC10.html)
ZA (1) ZA912652B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
WO1993006082A1 (en) * 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
US5310917A (en) * 1991-09-13 1994-05-10 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropydrines
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
DE4200714A1 (de) * 1992-01-14 1993-07-15 Bayer Ag Spezieller 1,4-dihydropyridin-3,5-dicarbonsaeureester, verfahren zu seiner herstellung und seine pharmazeutische verwendung
DE4223867A1 (de) * 1992-07-20 1994-01-27 Bayer Ag Spezieller 1,4-Dihydropyridin-3,5-dicarbonsäureester, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE4313691A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2,6-Disubstituierte 4-Chinolyl-dihydropyridine
DE4313692A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313697A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4328884A1 (de) * 1993-08-27 1995-03-02 Bayer Ag Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel
EP0657432B1 (de) * 1993-12-10 2003-03-12 Bayer Ag Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE4430094A1 (de) 1994-08-25 1996-02-29 Bayer Ag Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel
DE19638570A1 (de) * 1996-09-20 1998-03-26 Bayer Ag Wirkstoffhaltige thermoplastische Polyurethane
AU2002361992A1 (en) * 2001-12-20 2003-07-09 Bayer Aktiengesellschaft 1,4-dihydro-1,4-diphenylpyridine derivatives
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
CA2854252C (en) * 2011-11-24 2016-11-29 Lipidart Kutato Fejleszto Es Tanacsado Kft. 1,4-dihydropyridine derivatives with hsp modulating activity

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
US3883543A (en) * 1969-05-10 1975-05-13 Bayer Ag N-alkyl-1,4-dihydropyridines
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
CH550189A (de) * 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.
DE2210667A1 (de) * 1972-03-06 1973-09-20 Bayer Ag Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2228377A1 (de) * 1972-06-10 1974-01-03 Bayer Ag Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH569043A5 (cg-RX-API-DMAC10.html) * 1973-01-23 1975-11-14 Ciba Geigy Ag
US3956341A (en) * 1974-02-21 1976-05-11 Smithkline Corporation 1,3,5-Tricarbo-1,4-dihydropyridines
SU798099A1 (ru) * 1978-03-06 1981-01-23 Ордена Трудового Красного Знамениинститут Органического Синтезаан Латвийской Ccp 1-Бензил-2,6-диметил-4-о-или-M-НиТРОфЕНил-3,5-диэТОКСиКАРбОНил- 1,4-дигидРОпиРидиНы, пРО Вл ющиЕКОРОНАРОдилАТиРующую АКТиВНОСТь
EP0176956B1 (de) * 1984-09-28 1994-06-15 Byk Gulden Lomberg Chemische Fabrik GmbH Neue Diarylverbindungen
US4975440A (en) * 1984-09-28 1990-12-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Optically-active 1,4-dihydropyridine
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
GB8616047D0 (en) * 1986-07-01 1986-08-06 Sandoz Ltd A 1 4-dihydropyridine derivatives
GR1002248B (en) * 1988-03-08 1996-04-23 Egyt Gyogyszervegyeszeti Gyar 1,4-dihydropyridine derivatives preparation method

Also Published As

Publication number Publication date
ES2063998T3 (es) 1995-01-16
AU642992B2 (en) 1993-11-04
DE59102788D1 (de) 1994-10-13
US5432185A (en) 1995-07-11
FI101377B1 (fi) 1998-06-15
TW197423B (cg-RX-API-DMAC10.html) 1993-01-01
PT97300B (pt) 1998-10-30
JPH04234847A (ja) 1992-08-24
KR910018025A (ko) 1991-11-30
EP0451654A3 (en) 1992-07-08
EP0451654A2 (de) 1991-10-16
PT97300A (pt) 1992-01-31
ZA912652B (en) 1992-01-29
CA2040062A1 (en) 1991-10-12
US5234935A (en) 1993-08-10
IL97796A (en) 1995-03-15
KR0180741B1 (ko) 1999-03-20
HUT59905A (en) 1992-07-28
IE64452B1 (en) 1995-08-09
HU211313A9 (en) 1995-11-28
HU911184D0 (en) 1991-10-28
AU7425391A (en) 1991-10-17
EP0451654B1 (de) 1994-09-07
FI911700A0 (fi) 1991-04-09
JP3012352B2 (ja) 2000-02-21
DE4011695A1 (de) 1991-10-17
ATE111079T1 (de) 1994-09-15
FI911700A7 (fi) 1991-10-12
DK0451654T3 (da) 1995-02-13
IE911200A1 (en) 1991-10-23
IL97796A0 (en) 1992-06-21
FI101377B (fi) 1998-06-15

Similar Documents

Publication Publication Date Title
US5234935A (en) N-alkylated 1,4-dihydropyridine-dicarboxylic acid esters
FI61483B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-dihydropyridinkarboxylsyraalkylestrar
AU5320200A (en) Npy antagonists: spiroisoquinolinone derivatives
KR20030082890A (ko) Ｃｂ1-길항 활성을 갖는 4,5-디하이드로-1ｈ-피라졸 유도체
CA2156672A1 (en) 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments
US5328931A (en) N-alkylated 1,4-dihydropyridinedicarboxylic acid esters
US5646166A (en) Use of 5-acyl-1,4-dihydropyridines
AU616057B2 (en) Use of basic nitro-phenyl-dihydropyridine amides as medicaments, new compounds and processes for their preparation via new intermediates
NZ250085A (en) Use of dihydropyridinedicarboxylic acid esters as pharmaceuticals
EP2077993B1 (en) Method for the separation of s-(-)-amlodipine from racemic amlodipine
JPH02169572A (ja) ジヒドロピリジンアミド及びその生理学的に許容し得る塩
US5342847A (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester and its pharmaceutical use
JPS6289662A (ja) １，４−ジヒドロピリジン誘導体
SK158095A3 (en) Application of 1,2-bridged 1,4-dihydropyridines, 1,2-bridged 1,4-dihydropyridines, manufacturing process thereof and pharmaceutical compositions containing them
SK153194A3 (en) Phenylsubstituted 1,4-dihydropyridines, method of their production, their using and medicines which containing these matters
JPH01139577A (ja) １，４−ジヒドロピリジン誘導体
CA2156788A1 (en) Use of 6-amino-1,4-dihydropyridines as medicaments for treatment of the central nervous system, and processes for their preparation
PL156170B1 (pl) Sposób wytwarzania pochodnych 2-/aminoalkilotio/metylol,4-dihydropirydyny PL PL PL
HU198907B (en) Process for producing dihydropyridine derivatives and pharmaceutical compositions containing them as active components